Načítá se...
Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
Epidermal growth factor receptor (EGFR) mutations are present in 20–40% of non-small cell lung cancers (NSCLCs). Brain metastasis (BM) is more common in EGFR-mutated NSCLC (25–45%) compared to EGFR wild-type (15–30%). First and second-generation tyrosine kinase inhibitors (TKIs), such as erlotinib a...
Uloženo v:
| Vydáno v: | J Thorac Dis |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8182502/ https://ncbi.nlm.nih.gov/pubmed/34164215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-2019-rbmlc-04 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|